Tango Therapeutics, Inc.
TNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819133
In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Tango Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 121
- +21 vs. Q3 2023
- Shares held
- 93.6M
- +4.83M (+5.4%) vs. Q3 2023
- Total value
- $927.1M
- −$72.8M (−7.3%) vs. Q3 2023
- New holders
- 37
- 41 more added
- Sold out
- 16
- 22 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TNGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 247 | $6.60B |
| Q1 2026 | 194 | $3.78B |
| Q4 2025 | 170 | $1.53B |
| Q3 2025 | 141 | $1.18B |
| Q2 2025 | 115 | $651.7M |
| Q1 2025 | 122 | $147.0M |
| Q4 2024 | 138 | $329.2M |
| Q3 2024 | 121 | $781.2M |
| Q2 2024 | 120 | $846.0M |
| Q1 2024 | 126 | $781.2M |
| Q4 2023 | 121 | $927.1M |
| Q3 2023 | 100 | $999.9M |
| Q2 2023 | 89 | $226.8M |
| Q1 2023 | 92 | $275.9M |
| Q4 2022 | 82 | $498.4M |
| Q3 2022 | 87 | $246.8M |
| Q2 2022 | 77 | $319.1M |
| Q1 2022 | 72 | $528.2M |
| Q4 2021 | 58 | $741.0M |
| Q3 2021 | 46 | $844.9M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Tango Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 630,000 | $6.24M | 0.97% | 00.0% | Unchanged |
| Bessemer Group Inc | 708,384 | $7.01M | 0.01% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 708,385 | $7.01M | 0.08% | +708,385 | New |
| Baker Bros. Advisors LP | 750,000 | $7.42M | 0.08% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 847,145 | $8.39M | 0.93% | −1,081,874−56.1% | Reduced |
| State Street Corp | 978,938 | $9.69M | 0.00% | +25,059+2.6% | Added |
| Geode Capital Management, LLC | 1,097,102 | $10.9M | 0.00% | +62,108+6.0% | Added |
| Perceptive Advisors LLC | 1,111,870 | $11.0M | 0.25% | −1,307,098−54.0% | Reduced |
| Casdin Capital, LLC | 1,188,349 | $11.8M | 1.16% | −119,000−9.1% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 1,540,000 | $15.2M | 0.28% | +746,271+94.0% | Added |
| RTW Investments, LP | 1,966,752 | $19.5M | 0.30% | +1,966,752 | New |
| Bain Capital Life Sciences Investors, LLC | 2,892,663 | $28.6M | 2.74% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,979,212 | $29.5M | 0.00% | +39,369+1.3% | Added |
| Adage Capital Partners GP, L.L.C. | 3,400,000 | $33.7M | 0.07% | +1,645,148+93.7% | Added |
| BlackRock Inc. | 3,949,276 | $39.1M | 0.00% | +391,757+11.0% | Added |
| Southpoint Capital Advisors LP | 5,276,699 | $52.2M | 1.12% | 00.0% | Unchanged |
| Nextech Invest AG | 5,533,980 | $54.8M | 10.21% | 00.0% | Unchanged |
| Boxer Capital, LLC | 8,198,642 | $81.2M | 4.05% | +1,075,000+15.1% | Added |
| FMR LLC | 9,787,350 | $96.9M | 0.01% | −1,858,391−16.0% | Reduced |
| EcoR1 Capital, LLC | 13,330,736 | $132.0M | 3.43% | +4,609,100+52.8% | Added |
| TRV GP IV, LLC | 19,363,975 | $191.7M | 77.88% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −2,222,222−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −844,377−100.0% | Sold out |
| Harvard Management Co Inc | 0 | $0 | 0.00% | −708,385−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −209,401−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −47,337−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −35,020−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −30,988−100.0% | Sold out |
| Aviva Holdings Ltd. | 0 | $0 | 0.00% | −26,961−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −23,600−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −14,095−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −13,522−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −12,715−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −8,157−100.0% | Sold out |
| Mascoma Wealth Management LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| L2 Asset Management, LLC | 0 | $0 | 0.00% | −16,411−100.0% | Sold out |